Browse > Article
http://dx.doi.org/10.22722/KJPM.2019.27.1.60

Association between Thyroid-Related Hormones and Cognitive Function in Patients with Alzheimer's Disease and Mild Cognitive Impairment  

Park, Da Yun (Department of Psychiatry, Ilsan Paik Hospital, Inje University College of Medicine)
Kim, Hyun (Department of Psychiatry, Ilsan Paik Hospital, Inje University College of Medicine)
Lee, Kang Joon (Department of Psychiatry, Ilsan Paik Hospital, Inje University College of Medicine)
Publication Information
Korean Journal of Psychosomatic Medicine / v.27, no.1, 2019 , pp. 60-68 More about this Journal
Abstract
Objectives : The association between thyroid-related hormones and cognitive function has been controversial. The purpose of this study is to compare the levels of thyroid-related hormones in patients with Alzheimer's disease (AD) and mild cognitive impairment (MCI). Furthermore, we investigated the relationship between thyroid-related hormones and cognitive function. Methods : From January 2011 to December 2018, we retrospectively reviewed 105 patients who were diagnosed with AD and MCI by visiting a dementia clinic at Ilsan Paik Hospital. Thyroid-related hormones [triiodothyronine (T3), thyroxine (T4), and thyroid stimulating hormone (TSH)] was measured using chemiluminescent immunoassay. An independent sample t-test was performed to analyze the mean value of thyroid-related hormones in patients of AD and MCI. To investigate whether thyroid-related hormones correlate significantly with Global deterioration scale (GDS), Clinical dementia rating (CDR) and scores of each The Korean version of the consortium to establish a registry for Alzheimer's disease items, we conducted a partial correlation analysis with geriatric depression scale-Korean version (GDS-K) scores as covariates. Results : There was no significant difference in the mean serum T3, T4 and TSH levels between patients of the AD and the MCI, but the Construction Praxis Test (CPT) showed a significant positive correlation with the serum TSH concentration (p-value=0.004). Conclusions : In our study, the positive correlation between serum TSH level and the CPT associated with executive function was found to be helpful in understanding the association between thyroid-related hormones and the pathophysiology of dementia. Prospective studies in regard of the pathophysiology of thyroid-related hormones on cognitive function will be necessary in the future.
Keywords
Thyroid hormones; Alzheimer's disease; Mild cognitive impairment;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Annerbo S, Kivipelto M, Lokk J. A prospective study on the development of Alzheimer's disease with regard to thyroidstimulating hormone and homocysteine. Dement Geriatr Cogn Disord 2009;28:275-280.   DOI
2 Kim SH, Choi HJ, Lee HR. Thyroid status and dementia in old age. J Korean Acad Fam Med 2007;28:173-178.
3 Ceresini G, Lauretani F, Maggio M, Ceda GP, Morganti S, Usberti E, Chezzi C, Valcavi R, Bandinelli S, Guralnik JM, Cappola AR, Valenti G, Ferrucci L. Thyroid function abnormalities and cognitive impairment in elderly people: results of the Invecchiare in Chianti study. J Am Geriatr Soc 2009;57:89-93.   DOI
4 Kalmijn S, Mehta KM, Pols HA, Hofman A, Drexhage HA, Breteler MM. Subclinical hyperthyroidism and the risk of dementia. The Rotterdam study. Clin Endocrinol (Oxf) 2000;53:733-737.   DOI
5 Grigorova M, Sherwin BB. Thyroid hormones and cognitive functioning in healthy, euthyroid women: a correlational study. Horm Behav 2012;61:617-622.   DOI
6 Lee SN, Jin HY, Moon SW. Thyroid Hormones, Cognitive Impairment, Depression and Subjective Memory Complaint in Community-Dwelling Elders with Questionable Dementia in Korea. Korean J Biol Psychiatry 2014;21:175-181.
7 Wahlin A, Bunce D, Wahlin TB. Longitudinal evidence of the impact of normal thyroid stimulating hormone variations on cognitive functioning in very old age. Psychoneuroendocrinology 2005;30:625-637.   DOI
8 Zec RF. Neuropsychological functioning in Alzheimer's disease. In: Parks RW, Zec RF, Wilson RS, editors. Neuropsychology of Alzheimer's disease and other dementias. New York: Oxford University Press;1993. p.3-80.
9 Kinoshita K, Kawashima K, Kawashima Y, Fukuchi I, Yamamura M, Matsuoka Y. Effect of TA-0910, a novel thyrotropin-releasing hormone analog, on in vivo acetylcholine release and turnover in rat brain. Jpn J Pharmacol 1996;71:139-145.   DOI
10 Videla LA, Sir T, Wolff C. Increased lipid peroxidation in hyperthyroid patients: suppression by propylthiouracil treatment. Free Radic Res Commun 1988;5:1-10.   DOI
11 Chaker L, Wolters FJ, Bos D, Korevaar TI, Hofman A, van der Lugt A, Koudstaal PJ, Franco OH, Dehghan A, Vernooij MW, Peeters RP, Ikram MA. Thyroid function and the risk of dementia: the Rotterdam Study. Neurology 2016;87:1688-1695.   DOI
12 Chan RS, Huey ED, Maecker HL, Cortopassi KM, Howard SA, Iyer AM, McIntosh LJ, Ajilore OA, Brooke SM, Sapolsky RM. Endocrine modulators of necrotic neuron death. Brain Pathol 1996;6:481-491.   DOI
13 Statistics Korea. Korean Statistical Information Service: Population [Internet]. Daejeon (KR): Statistics Korea; c2017 [cited 2017 Jun 15]. Available from: http://kosis.kr/statisticsList/statisticsList_01List.jsp?vwcd=MT_ZTITLE&parentId=A.
14 Henderson AS. Epidemiology of dementia disorders. Adv Neurol 1990;51:15-25.
15 Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999;56:303-308.   DOI
16 Tan ZS, Beiser A, Vasan RS, Au R, Auerbach S, Kiel DP, Wolf PA, Seshadri S. Thyroid function and the risk of Alzheimer disease: the Framingham Study. Arch Intern Med 2008;168:1514-1520.   DOI
17 Toft AD, Boon NA. Thyroid disease and the heart. Heart 2000;84:455-460.   DOI
18 Reiman EM, Chen K, Alexander GE, Caselli RJ, Bandy D, Osborne D, Saunders AM, Hardy J. Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia. Proc Natl Acad Sci USA 2004;101:284-289.   DOI
19 Freemantle E, Vandal M, Tremblay-Mercier J, Tremblay S, Blachere JC, Begin ME, Brenna JT, Windust A, Cunnane SC. Omega-3 fatty acids, energy substrates, and brain function during aging. Prostaglandins Leukot Essent Fatty Acids 2006;75:213-220.   DOI
20 Hogervorst E, Huppert F, Matthews FE, Brayne C. Thyroid function and cognitive decline in the MRC Cognitive Function and Ageing Study. Psychoneuroendocrinology 2008;33:1013-1022.   DOI
21 Diez JJ, Molina I, Ibars MT. Prevalence of thyroid dysfunction in adults over age 60 years from an urban community. Exp Clin Endocrinol Diabetes 2003;111:480-485.   DOI
22 Hak AE, Pols HA, Visser TJ, Drexhage HA, Hofman A, Witteman JC. Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study. Ann Intern Med 2000;132:270-278.
23 Auer J, Scheibner P, Mische T, Langsteger W, Eber O, Eber B. Subclinical hyperthyroidism as a risk factor for atrial fibrillation. Am Heart J 2001;142:838-842.   DOI
24 Breteler MM. Vascular risk factors for Alzheimer's disease: an epidemiologic perspective. Neurobiol Aging 2000;21:153-160.   DOI
25 Kivipelto M, Helkala EL, Hanninen T, Laakso MP, Hallikainen M, Alhainen K, Soininen H, Tuomilehto J, Nissinen A. Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study. BMJ 2001;322:1447-1451.   DOI
26 Begin ME, Langlois MF, Lorrain D, Cunnane SC. Thyroid function and cognition during aging. Curr Gerontol Geriatr Res 2008:474868.
27 Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, Spencer CA, Braverman LE. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 2002;87:489-499.   DOI
28 Lopez O, Huff FJ, Martinez AJ, Bedetti CD. Prevalence of thyroid abnormalities is not increased in Alzheimer's disease. Neurobiol Aging 1989;10:247-251.   DOI
29 Ganguli M, Burmeister LA, Seaberg EC, Belle S, DeKosky ST. Association between dementia and elevated TSH: a community-based study. Biol Psychiatry 1996;40:714-725.   DOI
30 van Osch LA, Hogervorst E, Combrinck M, Smith AD. Low thyroid-stimulating hormone as an independent risk factor for Alzheimer disease. Neurology 2004;62:1967-1971.   DOI
31 Lee JH, Lee KU, Lee DY, Kim KW, Jhoo JH, Lee KH. Development of the Korean version of the consortium to establish a registry for alzheimer's disease (CERAD) Assessment packet (CERAD-K): Clinical and Neuropsychological assessment batteries. J Gernotol B Psyhol Sci 2002;57:47-53.   DOI
32 de Jongh RT, Lips P, van Schoor NM, Rijs KJ, Deeg DJ, Comijs HC, Kramer MH, Vandenbroucke JP, Dekkers OM. Endogenous subclinical thyroid disorders, physical and cognitive function, depression, and mortality in older individuals. Eur J Endocrinol 2011;165:545-554.   DOI
33 McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.   DOI
34 Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L, Wahlund LO, Nordberg A, Backman L, Albert M, Almkvist O, Arai H, Basun H, Blennow K, de Leon M, De- Carli C, Erkinjuntti T, Giacobini E, Graff C, Hardy J, Jack C, Jorm A, Ritchie K, van Duijn C, Visser P, Petersen RC. Mild cognitive impairment-beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med 2004;256:240-246.   DOI
35 Park JH, Kwon YC. Standardization of Korean Version of Mini-Mental State Examination (MMSE-K) Part I: Development of the Test for the Elderly. J Korean Neuropsychiatr Assoc 1989;28:125-135.
36 Morris JC. The clinical Dementia rating (CDR): current version and scoring rules. Neurology 1993;43:2412-2414.   DOI
37 Reisberg B, Ferris SH, de Leon MJ, Crook T. Global Deterioration scale (GDS). Psychopharmacol Bull 1988;24:661-663.
38 Hu Y, Wang ZC, Guo QH, Cheng W, Chen YW. Is thyroid status associated with cognitive impairment in elderly patients in China? BMC Endocr Disord 2016;16:11.   DOI
39 Bae JN, Cho MJ. Development of the Korean version of the Geriatric Depression scale and its form among elderly psychiatric patients. J psychosom Res 2004;57:297-305.   DOI
40 Quinlan P, Nordlund A, Lind K, Gustafson D, Edeman A, Wallin A. Thyroid hormones are associated with poorer cognition in mild cognitive impairment. Dement Geriatr Cogn Disord 2010;30:205-211.   DOI
41 Latasa MJ, Belandia B, Pascual A. Thyroid hormones regulate ${\beta}$-amyloid gene splicing and protein secretion in neuroblastoma cells. Endocrinology 1998;139:2692-2698.   DOI
42 de Jong FJ, Masaki K, Chen H, Remaley AT, Breteler MM, Petrovitch H, White LR, Launer LJ. Thyroid function, the risk of dementia and neuropathologic changes: the Honolulu- Asia aging study. Neurobiol Aging 2009;30:600-606.   DOI
43 Mitchell TW, Mufson EJ, Schneider JA, Cochran EJ, Nissanov J, Han LY, Bienias JL, Lee VM, Trojanowski JQ, Bennett DA, Arnold SE. Parahippocampal tau pathology in healthy aging, mild cognitive impairment, and early Alzheimer's disease. Ann Neurol 2002;51:182-189.   DOI
44 Gussekloo J, van Exel E, de Craen AJ, Meinders AE, Frolich M, Westendorp RG. Thyroid status, disability and cognitive function, and survival in old age. JAMA 2004;292:2591-2599.   DOI
45 Roberts LM, Pattison H, Roalfe A, Franklyn J, Wilson S, Hobbs FD, Parle JV. Is subclinical thyroid dysfunction in the elderly associated with depression or cognitive dysfunction? Ann Intern Med 2006;145:573-581.   DOI